The FDA has posted a new template for commercial developers to submit emergency use authorization (EUA) requests for COVID-19 diagnostic tests that can be performed entirely at home or in other everyday settings and that could be available without a prescription.
Read more: Coronavirus (COVID-19) Update: FDA Posts New Template for At-Home and Over-the-Counter Diagnostic Tests for Use in Non-Lab Settings, Such as Homes, Offices or Schools